• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests)

$3,750.00 – $7,500.00

Clear
SKU: 22-045 Category: Diagnostics Market Research Tags: at-home testing, COVID-19, FOB, glucose, HIV, Infectious Disease, Pregnancy Pages: 44
  • Description
  • Table of Contents
  • Latest reports

Description

The at-home IVD testing market is a growing market with much potential. This report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), analyzes at-home tests where the entire process is done at home. A sample is collected, and the results are provided in under one hour. This does not include self-collection at home and then sent to a laboratory where it can be analyzed.

This report is segmented into three areas:

  • Glucose
  • Infectious disease
  • Other areas

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests.  The base year for data was 2021. Data are provided for 2021 and 2026 with compound annual growth rates (CAGRs) for 2021 and 2026. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, EMEA, Asia-Pacific and Rest of World for 2019-2021.  The forecasted market analysis for 2021-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

Chapter 1. Executive Summary

Industry at a Glance

Scope and Methodology

Size and Growth of the Market

  • Figure 1-1: Global At-Home IVD Market by Key Segment (Glucose, COVID-19, Other), 2019-2021

Key Issues and Trends Affecting the Market

Competitive Outlook

Conclusion Highlights

 

Chapter 2:  Introduction

Overview

At-Home Tests by Test Type

  • Table 2-1: Global At-Home IVD Market by Test Type, 2021 ($BN)
  • Figure 2-1: Global At-Home IVD Market by Distribution of Sales by Segment (Glucose, COVID-19, HIV, Other Infections, Cholesterol, Drug of Abuse, Coagulation, FOB, Pregnancy & Fertility, Other), 2021

At-Home Tests by Sample Type

  • Table 2-2: Global At-Home IVD Market by Sample Type, 2021 ($BN)
  • Figure 2-2: Global At-Home IVD Market by Distribution of Sales by Sample Type (Blood, Urine, Oral/Saliva, Nasal, Stool, Other), 2019 and 2021

Blood Samples

  • Figure 2-3: Estimated Distribution of Blood Sample Sales by Test Type, 2021

Urine Samples

  • Figure 2-4: Estimated Distribution of Urine Sample Sales by Test Type, 2021

Oral/Saliva Samples

  • Figure 2-5: Estimated Distribution of Oral/Saliva Sample Sales by Test Type, 2021

Nasal Samples

  • Figure 2-6: Estimated Distribution of Nasal Sample Sales by Test Type, 2021

Stool Samples

  • Figure 2-7: Estimated Distribution of Stool Sample Sales by Test Type, 2021

Other

 

Chapter 3:  Issues and Trends

COVID-19

At-Home COVID-19 Test Distribution of Sales by Vendor

Insurance for At-Home Tests

Diabetes State Mandates – State-Level Insurance Mandates for Benefits, ACA Marketplace Coverage

At-Home IVD Testing Drivers and Challenges

 

Chapter 4: Market Participants

Abbott

  • Table 4-1: Corporate Summary

Company Overview

Acon Laboratories, Inc.

  • Table 4-2:  Acon Laboratories Corporate Summary

Company Overview

Ascensia Diabetes Care Holdings AG

  • Table 4-3: Ascensia Diabetes Care Corporate Summary

Company Overview

Becton-Dickinson

  • Table 4-4:  Becton-Dickinson Corporate Summary

Company Overview

Dexcom, Inc.

  • Table 4-5:  Dexcom Corporation Corporate Summary

Company Overview

OraSure Technologies, Inc.

  • Table 4-6:  OraSure Technologies Summary

Company Overview

Quidel Corporation

  • Table 4-7:  Quidel Corporate Summary

Company Overview

Roche Diagnostic Corporation

  • Table 4-8:  Roche Diagnostic Corporate Summary

Company Overview

Siemens Healthineers GmbH

  • Table 4-9: Siemens Healthineers Corporate Summary

Company Overview

Swiss Precision Diagnostics GmbH

  • Table 4-10:  Swiss Precision Diagnostics Corporate Summary

Company Overview

 

Chapter 5: Market Analysis

  • Market Overview
  • Figure 5-1: Global At-Home IVD Market, 2021-2026, 8% CAGR, (S MN)
  • Figure 5-2: Year-over-Year Growth (’19-20, ’20-21) for At-Home IVD Markets, %

Market Segment by Test Type

  • Figure 5-3: Global At-Home IVD Market by Test Type, 2019-2021 ($MN)
  • Figure 5-4: Global At-Home IVD Market by General Test Segment, 2021

Glucose

  • Table 5-1: Estimated Global At-Home IVD Glucose Testing Market, 2021-2026 $MN; CAGR 21-26

Infectious Disease

  • Table 5-2: Estimated Global At-Home IVD Infectious Disease Testing Market, 2021-2026 $MN; CAGR 21-26

Other Areas

  • Table 5-3: Estimated Global At-Home IVD Other (Cholesterol, Coagulation, Drug of Abuse, Fecal Occult Blood, Pregnancy/Fertility, Other) Testing Market, 2021-2026 $MN; CAGR 21-26

Market by Region

  • Figure 5-5: Estimated Global At-Home IVD Testing Market by Region, 2019-2021

Competitive Analysis

Top Five Market Leaders

  • Figure 5-6: Estimated Global At-Home IVD Testing Market, Vendor Market Share 2021

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    $4,995.00 – $9,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Market and Future Potential for Molecular Point of Care (POC), 2022Infectious Disease Diagnostic Testing: World Market Analysis
Scroll to top